merck

So the Elkton site finally got rid of someone this week that should have been taken care of years ago. With everything Merck preaches about diversity, non retaliation, non confrontation, etc., this guy went against all of this for 20+ years, plus sexual harassment and generally treating...

What do the salaries look like for P5 Medical Affairs positions at this company?

Anyone know what Syneos is giving out for fleet vehicles nowadays? Just got first contract in pharma and this is new to me

What’s up with Syneos Talent Acquisition??? They stalk you. Ask the dumbest questions in the world and no zero about the products? Then they ghost. LOL.

Merck surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in premarket hours on Tuesday. Worldwide sales rose 15% year-over-year to $12.4 billion, beating estimates of $11.6 billion. Excluding foreign exchange impacts, sales...

Curious if anyone can share information about expected salary range for oncology reps for Merck for the expansion? Bonus structure? What kind of company car? etc.

Are there any Merck Animal Health reps in this forum? Anybody know Glen Casada in Nashville? Supposedly he is a Merck Animal Health rep and I'm just trying to confirm.

Novo Nordisk says pricing pressure within diabetes to continue, especially in the US. First quarter 2019 results: Sales from North America Operations declined 4% on constant exchange rates.

Axsome Therapeutics stock skyrockets on positive outcome from Alzheimer's disease trial https://news.alphastreet.com/axsome-therapeutics-nasdaq-axsm-stock-almost-doubles-on-positive-outcome-from-alzheimers-disease-trial-in-premarket/

Eli Lilly to collaborate with AC Immune for the treatment of Alzheimer’s disease. Will it succeed and create a drug to cure Alzheimer's disease?

Merck creates two new executive positions; CCO and CMO. Adam Schechter, President of GHH becomes an advisor to Ken Frazier

What's the reason for Celgene going down even after beating the estimates and lifting 2018 outlook? Any thoughts? https://news.alphastreet.com/celgene-celg-stock-q3-2018-earnings/

Pharma giant Merck reported a 12.4% dip in earnings for the second quarter due to a 28% increase in research and development costs, as well as a 10% rise in materials and production costs, despite a 24% dip in income taxes. The top and bottom line came in above analysts’ expectations. The top...

Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...

The latest pharma giant to bow to Trump’s pressure on drug price is Merck (MRK). The company announced on Thursday that it would lower price on at least six of its drug in the US by 10% or more. https://news.alphastreet.com/merck-joins-pharma-giants-in-lowering-drug-prices/

Trump has been speaking and tweeting about the higher drug prices for nearly two years and still he has not taken any steps in reducing the prices of the drugs. Pfizer and other pharma companies are taking advantage and increasing their drug prices often. When will this stop...

saving the best drug for last

Merck reported a 6% increase in worldwide sales to $10 billion for the first quarter of 2018 compared to the prior year period. Pharmaceutical sales grew 9% to $8.9 billion driven primarily by growth in oncology, hospital acute care and diabetes. This was partially offset by lower sales in...

http://www.cafepharma.com/boards/threads/the-new-reality-of-whats-left-of-merck-employees.609591/ At least it's not so bad in IT. It's not like our clients have zero confidence in us or outright despise us since the cybersecurity incident and our leadership still have no clue. Merck -...

After weeks of offers and speculations, a deal has finally been struck in the consumer health space, though not really in an expected manner. P&G has ditched Pfizer’s consumer health unit to buy the same business of rival Merck, which was eyed by Mylan NV. P&G was willing to pay $15 billion for...